NDC 69751-100

Phexxi

Lactic Acid, L-, Citric Acid Monohydrate, And Potassium Bitartrate

Phexxi is a Vaginal Gel in the Human Prescription Drug category. It is labeled and distributed by Evofem, Inc.. The primary component is Lactic Acid, L-; Citric Acid Monohydrate; Potassium Bitartrate.

Product ID69751-100_6b87bcf6-b3a8-4a3b-b42f-aaa70c1caf6d
NDC69751-100
Product TypeHuman Prescription Drug
Proprietary NamePhexxi
Generic NameLactic Acid, L-, Citric Acid Monohydrate, And Potassium Bitartrate
Dosage FormGel
Route of AdministrationVAGINAL
Marketing Start Date2020-08-01
Marketing CategoryNDA / NDA
Application NumberNDA208352
Labeler NameEvofem, Inc.
Substance NameLACTIC ACID, L-; CITRIC ACID MONOHYDRATE; POTASSIUM BITARTRATE
Active Ingredient Strength90 mg/5g; mg/5g; mg/5g
Pharm ClassesAcidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69751-100-12

12 APPLICATOR in 1 BOX (69751-100-12) > 5 g in 1 APPLICATOR (69751-100-01)
Marketing Start Date2020-09-01
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Phexxi]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PHEXXI
PHEXXI
88910069 not registered Live/Pending
Evofem Biosciences, Inc.
2020-05-11
PHEXXI
PHEXXI
88910057 not registered Live/Pending
Evofem Biosciences, Inc.
2020-05-11
PHEXXI
PHEXXI
88910026 not registered Live/Pending
Evofem Biosciences, Inc.
2020-05-11
PHEXXI
PHEXXI
88596085 not registered Live/Pending
Evofem Biosciences, Inc.
2019-08-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.